Tonix Pharma (TNXP) Tops Q2 EPS by 297c

Tonix Pharma (NASDAQ: TNXP) reported Q2 EPS of ($3.86), $2.97 better than the analyst estimate of ($6.83). Revenue for the quarter came in at $2 million versus the consensus estimate of $2.55 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• BofA says convenience store sales trail broader retail channels
• Klarna shares tumble on weak full-year revenue guidance
• Analog Devices (ADI) call put ratio 1.2 calls to 1 put into quarter results